Alicia J. Hager
CIK 1553354 · View on SEC EDGAR ↗
First SEC filing: Jan. 12, 2021 · Latest: Jan. 12, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2025 | NKTX | S | 9,584 | $2.20 | $21,085 | 146,735 Direct | -6.13% | Disposed | 15.4% (price as of 2026-08-21) |
| July 16, 2024 | NKTX | S 10b5-1 | 3,396 | $8.00 | $27,168 | 103,819 Direct | -3.17% | Disposed | -68.3% (price as of 2026-08-21) |
| June 18, 2024 | NKTX | S | 727 | $5.60 | $4,071 | 107,215 Direct | -0.67% | Disposed | -54.7% (price as of 2026-08-21) |
| Jan. 16, 2024 | NKTX | S | 4,554 | $8.74 | $39,802 | 107,942 Direct | -4.05% | Disposed | -71.0% (price as of 2026-08-21) |
| June 20, 2023 | NKTX | S | 701 | $4.85 | $3,400 | 56,496 Direct | -1.23% | Disposed | -47.7% (price as of 2026-08-21) |
| Jan. 17, 2023 | NKTX | S | 1,103 | $5.49 | $6,055 | 57,197 Direct | -1.89% | Disposed | -53.8% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 3, 2025 | NKTX | Stock Option (right to buy) | Common Stock (105,000) | $2.50 | Jan. 2, 2035 | 105,000 | Acquired |
| Jan. 4, 2024 | NKTX | Stock Option (right to buy) | Common Stock (112,500) | $6.01 | Jan. 3, 2034 | 112,500 | Acquired |
| Jan. 13, 2023 | NKTX | Stock Option (right to buy) | Common Stock (75,000) | $5.57 | Jan. 12, 2033 | 75,000 | Acquired |
| June 17, 2022 | NKTX | Stock Option (right to buy) | Common Stock (50,500) | $12.25 | June 16, 2032 | 50,500 | Acquired |
| Jan. 14, 2022 | NKTX | Stock Option (right to buy) | Common Stock (20,000) | $12.14 | Jan. 13, 2032 | 20,000 | Acquired |
| Jan. 14, 2022 | NKTX | Stock Option (right to buy) | Common Stock (76,800) | $12.14 | Jan. 13, 2032 | 76,800 | Acquired |
| Jan. 8, 2021 | NKTX | Stock Option (right to buy) | Common Stock (13,125) | $54.89 | Jan. 7, 2031 | 13,125 | Acquired |
| Oct. 26, 2020 | NKTX | Stock Option (right to buy) | Common Stock (150,000) | $31.11 | Oct. 25, 2030 | 150,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
NKTX
J.D., Ph.D.Chief Legal Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $415,565 | — | $253,392 | $1,214,886 | $166,226 | — | $9,150 | $2,059,219 |
| 2020 | $72,386 | — | — | — | $23,400 | — | $2,366 | $3,279,966 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.